Have a personal or library account? Click to login
Clinical Evolution of Patients with Schizophrenia Associated with Addictive Disorders Cover

Clinical Evolution of Patients with Schizophrenia Associated with Addictive Disorders

Open Access
|Dec 2020

Abstract

Introduction: The prevalence of schizophrenia in the general population is about 0.3% -0.7% Pathological use of substances such as cocaine, alcohol, amphetamines and nicotine are common in schizophrenia with a lifetime prevalence of 80%. They tend to isolate themselves in an inner world, thus being prone to substance abuse. The most commonly used substances are: alcohol, nicotine, cocaine, amphetamines, hallucinogens and cannabis.

Method: We conducted a retrospective, descriptive-analytical study on a group of 139 patients with a positive diagnosis of schizophrenia from the Psychiatry Clinic I of the Mureș County Clinical Hospital hospitalized between 01.01.2018-31.12.2019. The clinical and paraclinical data used were processed from observation sheets in the clinic archive. These were introduced and analyzed in the Microsoft Excel 2016 program, and the statistical test used was Chi Square in the Graph-Pad statistical analysis program.

Results: Most patients with schizophrenia have a schizoid (41%) and paranoid (32%) personality. Other types are: organic 25% (unstable and impulsive) and obsessive anxiety 2%. Due to the evolution of diseases, patients end up consuming psychoactive substances, tobacco and alcohol. A percentage of 48% of patients were tobacco consumers, 37% were alcohol consumers and 15% consumed psychoactive substances. Tobacco use is not a statistically significant factor in the recurrence of the disease.

Conclusions: Alcohol, tobacco and psychoactive substances are an important risk factor in the unfavorable evolution of the disease, most hospitalized patients are in the age group 50-59 years.

DOI: https://doi.org/10.2478/amma-2020-0033 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 152 - 154
Submitted on: Oct 30, 2020
Accepted on: Nov 24, 2020
Published on: Dec 31, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Andreea Salcudean, Melinda Ferencz, Daniela Sabau, Madalina Gherman, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.